Cover Image
市場調查報告書

基因學的全球市場 - 至2020年的趨勢與預測:各產品、技術 (定序、PCR、微陣列)、用途、流程、終端用戶、地區

Genomics Market by Product (Instruments, Consumables), Technology (Sequencing, PCR, Microarray), Application (Diagnostics, Personalized Medicine), Process (Library Preparation, Sequencing & Imaging), End User - Trends & Global Forecasts to 2020

出版商 MarketsandMarkets 商品編碼 294503
出版日期 內容資訊 英文 196 Pages
訂單完成後即時交付
價格
Back to Top
基因學的全球市場 - 至2020年的趨勢與預測:各產品、技術 (定序、PCR、微陣列)、用途、流程、終端用戶、地區 Genomics Market by Product (Instruments, Consumables), Technology (Sequencing, PCR, Microarray), Application (Diagnostics, Personalized Medicine), Process (Library Preparation, Sequencing & Imaging), End User - Trends & Global Forecasts to 2020
出版日期: 2016年02月24日 內容資訊: 英文 196 Pages
簡介

基因學市場,至2020年達到199億9千萬美元,預計2015年∼2020年以9.9%的年複合成長率成長。主要的成長推動因素,為政府的投資、津貼、資金的增加,研究的高漲,新興企業的增加,診斷的基因序列測定法的增加。

本報告提供全球基因學市場相關調查分析,市場概要,產業趨勢,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 全球基因學市場概要
  • 全球基因學市場:各技術
  • 基因學市場各地區分析:各終端用戶
  • 全球基因學市場:各流程
  • 基因學市場各地區概要

第5章 市場概要

  • 簡介
  • 演進
  • 市場區隔
  • 市場動態
    • 推動因素
    • 阻礙因素
    • 機會
    • 課題

第6章 全球基因學市場:各產品

  • 簡介
  • 設備/系統
  • 消耗品
  • 服務

第7章 全球基因學市場:各技術

  • 簡介
  • 定序
  • 微陣列技術
  • PCR (聚合酵素鏈鎖反應)
  • 核酸開採、煉製
  • 其他

第8章 全球基因學市場:各流程

  • 簡介
  • 程序庫調整
  • 定序、成像
  • 資料分析

第9章 全球基因學市場:各用途

  • 簡介
  • 診斷
  • 藥物研發
  • 個體化醫療
  • 農業、動物研究
  • 其他

第10章 全球基因學市場:各終端用戶

  • 簡介
  • 研究中心、學術機構、政府機關
  • 醫院、診療所
  • 製藥、生物科技企業
  • 其他

第11章 全球基因學市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第12章 競爭情形

  • 概要
  • 市場佔有率分析
  • 競爭情形與趨勢

第13章 企業簡介 (概要、財務、產品與服務、策略、發展等)

  • 簡介
  • THERMO FISHER SCIENTIFIC, INC.
  • AGILENT TECHNOLOGIES, INC.
  • AFFYMETRIX, INC.
  • BEIJING GENOMICS INSTITUTE (BGI)
  • BIO-RAD LABORATORIES, INC.
  • CEPHEID, INC.
  • EUROFINS GENOMICS, INC. (EUROFINS SCIENTIFIC GROUP的子公司)
  • GE HEALTHCARE
  • ILLUMINA, INC.
  • QIAGEN N.V.
  • ROCHE HOLDING AG

第14章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BT 2209

The genomics market is poised to reach USD 19.99 billion by 2020, growing at a CAGR of 9.9% during the forecast period of 2015 to 2020. The major factors driving the growth of the global genomics market include increasing investments, grants, and funds by the government; increasing research in the field of genomics; increasing number of start-up companies; and increasing application of genomic sequencing in the diagnostics. Despite the large number of benefits like detection of genetic variations in a diseased condition, high costs of genomic sequencing instruments/systems are restraining the genomics market.

The applications of genomics technologies have witnessed growth in recent years, which can be primarily attributed to the availability of advanced systems as well as the low cost of conducting sequencing. The technological advancement is evident from the number of improved versions of existing sequencers released in recent years. For instance, in January 2014, the leading player in the genomics market, Illumina, Inc. (U.S.), launched its NextSeq 500 System, which combines high-throughput performance with an affordable desktop form factor. This system is expected to enable researchers to perform sequencing in less than a day. In addition, the company also launched the NextSeq 500 System in January 2014, which combines high-throughput performance with an affordable desktop form factor. This system is expected to enable researchers to perform sequencing in less than a day.

In 2015, the consumables segment is accounted for the major share of the global genomics market, by product, while the diagnostics segment is expected to account for the largest share of genomics market, by application. The academic institutes, research centers, government institutes accounted for major share of the genomics end users market in 2015. Additionally, the PCR accounted for the largest share of the genomics market, by technology, in 2015

In 2015, North America is expected to account for the largest share of the global genomics market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). North America's large share is attributed to the passage of Personalized Medicine Initiative in 2015. The new healthcare initiative will increase the adaptation of genomics in personalized medicine and provide better treatment to the patients.

The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (agreements, partnerships, joint ventures, collaborations, geographic expansion, new product launches, and acquisitions) to increase their market shares and establish a strong foothold in the global market.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms to garner a greater market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of top players in the genomics market. The report analyzes the genomics market, by product, technology, process, end user, application, and region
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the genomics market
  • Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various genomics products and services across regions
  • Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the genomics market
  • Competitive Assessment: In-depth assessment of market shares, strategies, and products of the leading players in the genomics market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
  • 2.2. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.2.1. SECONDARY RESEARCH
      • 2.2.1.1. Key data from secondary sources
    • 2.2.2. PRIMARY RESEARCH
      • 2.2.2.1. Key industry insights
      • 2.2.2.2. Key data from primary sources
      • 2.2.2.3. Key Insights from primary sources
  • 2.3. MARKET SIZE ESTIMATION METHODOLOGY
  • 2.4. MARKET FORECAST METHODOLOGY
  • 2.5. MARKET DATA VALIDATION AND TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CURRENT SCENARIO
  • 3.3. FUTURE OUTLOOK
  • 3.4. GROWTH STRATEGIES

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL GENOMICS MARKET OVERVIEW
  • 4.2. GLOBAL GENOMICS MARKET, BY TECHNOLOGY
  • 4.3. GEOGRAPHIC ANALYSIS OF THE GENOMICS MARKET, BY END USER
  • 4.4. GLOBAL GENOMICS MARKET, BY PROCESS
  • 4.5. GEOGRAPHICAL SNAPSHOT OF THE GENOMICS MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. EVOLUTION
  • 5.3. MARKET SEGMENTATION
  • 5.4. MARKET DYNAMICS
    • 5.4.1. DRIVERS
      • 5.4.1.1. Rising government funding and growth in the number of genomics projects
      • 5.4.1.2. Decreasing sequencing costs
      • 5.4.1.3. Growing application areas of genomics
      • 5.4.1.4. Increasing awareness of genomics
      • 5.4.1.5. Entry of new players and start-ups in the genomics market
    • 5.4.2. RESTRAINTS
      • 5.4.2.1. High cost of genomic equipment
      • 5.4.2.2. Privacy issues related to genetic information
      • 5.4.2.3. Shortage of trained professionals
    • 5.4.3. OPPORTUNITY
      • 5.4.3.1. Use of genomics in specialized/personalized medicine
    • 5.4.4. CHALLENGE
      • 5.4.4.1. Secure storage of large volume of sequenced data

6. GLOBAL GENOMICS MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. INSTRUMENTS/SYSTEMS
  • 6.3. CONSUMABLES
  • 6.4. SERVICES

7. GLOBAL GENOMICS MARKET, BY TECHNOLOGY

  • 7.1. INTRODUCTION
  • 7.2. SEQUENCING
  • 7.3. MICROARRAY TECHNOLOGY
  • 7.4. PCR (POLYMERASE CHAIN REACTION)
  • 7.5. NUCLEIC ACID EXTRACTION AND PURIFICATION
  • 7.6. OTHER TECHNOLOGIES

8. GLOBAL GENOMICS MARKET, BY PROCESS

  • 8.1. INTRODUCTION
  • 8.2. LIBRARY PREPARATION
  • 8.3. SEQUENCING AND IMAGING
  • 8.4. DATA ANALYSIS

9. GLOBAL GENOMICS MARKET, BY APPLICATION

  • 9.1. INTRODUCTION
  • 9.2. DIAGNOSTICS
    • 9.2.1. CANCER DIAGNOSTICS
    • 9.2.2. MONOGENIC (MENDELIAN) DISORDERS
    • 9.2.3. OTHER DIAGNOSTIC APPLICATIONS
      • 9.2.3.1. Movement disorders
      • 9.2.3.2. HIV
  • 9.3. DRUG DISCOVERY AND DEVELOPMENT
  • 9.4. PERSONALIZED MEDICINE
  • 9.5. AGRICULTURE & ANIMAL RESEARCH
  • 9.6. OTHER APPLICATIONS

10. GLOBAL GENOMICS MARKET, BY END USER

  • 10.1. INTRODUCTION
  • 10.2. RESEARCH CENTERS, ACADEMIC INSTITUTES, AND GOVERNMENT INSTITUTES
  • 10.3. HOSPITALS AND CLINICS
  • 10.4. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 10.5. OTHER END USERS

11. GLOBAL GENOMICS MARKET, BY REGION

  • 11.1. INTRODUCTION
  • 11.2. NORTH AMERICA
    • 11.2.1. U.S.
      • 11.2.1.1. Research grants and funding by government institutes
      • 11.2.1.2. U.S. Precision Medicine Initiative
      • 11.2.1.3. Presence of top players together with their collaborations, investments, and partnerships
    • 11.2.2. CANADA
      • 11.2.2.1. The new pan-Canadian program in Canada
  • 11.3. EUROPE
    • 11.3.1. CONFERENCES AND MEETINGS IN EUROPE
    • 11.3.2. U.K.
      • 11.3.2.1. 100,000 Genome Project in UK
    • 11.3.3. GERMANY
      • 11.3.3.1. Academic institutes to boost the genomics market in Germany
    • 11.3.4. ROE
      • 11.3.4.1. Turkey to offer growth opportunities
  • 11.4. ASIA-PACIFIC
    • 11.4.1. PLAYERS FOCUS ON IMPROVING THEIR PRESENCE IN ASIA-PACIFIC
    • 11.4.2. CHINA
      • 11.4.2.1. Western partnerships in China aimed at improving healthcare
      • 11.4.2.2. BGI's contribution to market growth
    • 11.4.3. INDIA
      • 11.4.3.1. Emergence of local players in India backed by funding from the government
    • 11.4.4. JAPAN
      • 11.4.4.1. Collaborations between key global and local players
    • 11.4.5. REST OF ASIA-PACIFIC
      • 11.4.5.1. Alliances and partnerships in the genomics market to boost the Australian market
  • 11.5. REST OF THE WORLD (ROW)
    • 11.5.1. MIDDLE EAST AND AFRICA
      • 11.5.1.1. Saudi Human Genome project
    • 11.5.2. LATIN AMERICA
      • 11.5.2.1. Investments in research and innovation centers and conferences & workshops in Brazil

12. COMPETITIVE LANDSCAPE

  • 12.1. OVERVIEW
  • 12.2. MARKET SHARE ANALYSIS
    • 12.2.1. ILLUMINA, INC. (U.S.)
    • 12.2.2. BEIJING GENOMICS INSTITUTE (CHINA)
    • 12.2.3. EUROFINS GENOMICS (GERMANY)
    • 12.2.4. QIAGEN N.V. (NETHERLANDS)
    • 12.2.5. THERMO FISHER SCIENTIFIC, INC. (U.S.)
    • 12.2.6. AGILENT TECHNOLOGIES, INC. (U.S.)
    • 12.2.7. AFFYMETRIX, INC. (U.S.)
    • 12.2.8. OTHER PLAYERS
  • 12.3. COMPETITIVE SITUATION AND TRENDS
    • 12.3.1. NEW PRODUCT LAUNCHES
    • 12.3.2. AGREEMENTS, CONTRACTS, PARTNERSHIPS, AND COLLABORATIONS
    • 12.3.3. ACQUISITIONS
    • 12.3.4. EXPANSIONS
    • 12.3.5. OTHER DEVELOPMENTS

13. COMPANY PROFILES (Overview, Financials, Products & Services, Strategy, & Developments)*

  • 13.1. INTRODUCTION
  • 13.2. THERMO FISHER SCIENTIFIC, INC.
  • 13.3. AGILENT TECHNOLOGIES, INC.
  • 13.4. AFFYMETRIX, INC.
  • 13.5. BEIJING GENOMICS INSTITUTE (BGI)
  • 13.6. BIO-RAD LABORATORIES, INC.
  • 13.7. CEPHEID, INC.
  • 13.8. EUROFINS GENOMICS, INC. (SUBSIDIARY OF EUROFINS SCIENTIFIC GROUP)
  • 13.9. GE HEALTHCARE
  • 13.10. ILLUMINA, INC.
  • 13.11. QIAGEN N.V.
  • 13.12. ROCHE HOLDING AG

*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

14. APPENDIX

  • 14.1. DISCUSSION GUIDE
  • 14.2. COMPANY DEVELOPMENTS (2012-2015)
    • 14.2.1. THERMO FISHER SCIENTIFIC, INC.
    • 14.2.2. AGILENT TECHNOLOGIES, INC.
    • 14.2.3. AFFYMETRIX, INC.
    • 14.2.4. BEIJING GENOMICS INSTITUTE (BGI)
    • 14.2.5. BIO-RAD LABORATORIES, INC
    • 14.2.6. EUROFINS GENOMICS, INC.
    • 14.2.7. ILLUMINA, INC.
    • 14.2.8. QIAGEN N.V.
    • 14.2.9. ROCHE HOLDING AG
  • 14.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 14.4. AVAILABLE CUSTOMIZATIONS
  • 14.5. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: INCREASING GOVERNMENT FUNDING AND GROWTH IN THE NUMBER OF GENOMICS PROJECTS TO DRIVE THE GROWTH OF THE GLOBAL GENOMICS MARKET
  • TABLE 2: HIGH COST OF EQUIPMENT IS RESTRAINING THE GROWTH OF THE GLOBAL GENOMICS MARKET
  • TABLE 3: USE OF GENOMICS IN SPECIALIZED/PERSONALIZED MEDICINE IS A MAJOR OPPORTUNITY IN THE GENOMICS MARKET
  • TABLE 4: SECURE STORAGE OF LARGE VOLUME OF SEQUENCED DATA IS A MAJOR CHALLENGE IN THE GENOMICS MARKET
  • TABLE 5: GENOMICS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 6: GENOMICS INSTRUMENTS/SYSTEMS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 7: GENOMICS CONSUMABLES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 8: GENOMICS SERVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 9: GENOMICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 10: GENOMICS MARKET SIZE FOR SEQUENCING, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 11: GENOMICS MARKET SIZE FOR MICROARRAY TECHNOLOGY, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 12: GENOMICS MARKET SIZE FOR POLYMERASE CHAIN REACTION, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 13: GENOMICS MARKET SIZE FOR NUCLEIC ACID EXTRACTION AND PURIFICATION, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 14: GENOMICS MARKET SIZE FOR OTHER TECHNOLOGIES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 15: GENOMICS MARKET SIZE, BY PROCESS, 2013-2020 (USD MILLION)
  • TABLE 16: GENOMICS LIBRARY PREPARATION MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 17: GENOMICS SEQUENCING AND IMAGING MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 18: GENOMICS DATA ANALYSIS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 19: GENOMICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 20: GENOMICS MARKET SIZE FOR DIAGNOSTICS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 21: GENOMICS MARKET SIZE FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 22: GENOMICS MARKET SIZE FOR PERSONALIZED MEDICINE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 23: GENOMICS MARKET SIZE FOR AGRICULTURE AND ANIMAL RESEARCH, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 24: OTHER GENOMICS APPLICATIONS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 25: GENOMICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 26: GENOMICS MARKET SIZE FOR RESEARCH CENTERS, ACADEMIC INSTITUTES, AND GOVERNMENT INSTITUTES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 27: GENOMICS MARKET SIZE FOR HOSPITALS AND CLINICS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 28: GENOMICS MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 29: GENOMICS MARKET SIZE FOR OTHER END USERS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 30: GENOMICS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 31: NORTH AMERICA: GENOMICS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 32: NORTH AMERICA: GENOMICS MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 33: NORTH AMERICA: GENOMICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 34: NORTH AMERICA: GENOMICS MARKET SIZE, BY PROCESS, 2013-2020 (USD MILLION)
  • TABLE 35: NORTH AMERICA: GENOMICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 36: NORTH AMERICA: GENOMICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 37: U.S.: GENOMICS MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 38: U.S.: GENOMICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 39: U.S.: GENOMICS MARKET SIZE, BY PROCESS, 2013-2020 (USD MILLION)
  • TABLE 40: U.S.: GENOMICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 41: U.S.: GENOMICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 42: CANADA: GENOMICS MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 43: CANADA: GENOMICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 44: CANADA: GENOMICS MARKET SIZE, BY PROCESS, 2013-2020 (USD MILLION)
  • TABLE 45: CANADA: GENOMICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 46: CANADA: GENOMICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 47: CONFERENCES HELD IN EUROPE BETWEEN 2014 AND 2016
  • TABLE 48: EUROPE: GENOMICS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 49: EUROPE: GENOMICS MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 50: EUROPE: GENOMICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 51: EUROPE: GENOMICS MARKET SIZE, BY PROCESS, 2013-2020 (USD MILLION)
  • TABLE 52: EUROPE: GENOMICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 53: EUROPE: GENOMICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 54: U.K.: GENOMICS MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 55: U.K.: GENOMICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 56: U.K.: GENOMICS MARKET SIZE, BY PROCESS, 2013-2020 (USD MILLION)
  • TABLE 57: U.K.: GENOMICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 58: U.K.: GENOMICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 59: GERMANY: GENOMICS MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 60: GERMANY: GENOMICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 61: GERMANY: GENOMICS MARKET SIZE, BY PROCESS, 2013-2020 (USD MILLION)
  • TABLE 62: GERMANY: GENOMICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 63: GERMANY: GENOMICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 64: ROE : GENOMICS MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 65: ROE: GENOMICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 66: ROE: GENOMICS MARKET SIZE, BY PROCESS, 2013-2020 (USD MILLION)
  • TABLE 67: ROE: GENOMICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 68: ROE: GENOMICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 69: ASIA-PACIFIC: GENOMICS MARKET SIZE, BY COUNTRY/REGION, 2013-2020 (USD MILLION)
  • TABLE 70: ASIA-PACIFIC: GENOMICS MARKET SIZE, BY PRODUCT AND SERVICE, 2013-2020 (USD MILLION)
  • TABLE 71: ASIA-PACIFIC: GENOMICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 72: ASIA-PACIFIC: GENOMICS MARKET SIZE, BY PROCESS, 2013-2020 (USD MILLION)
  • TABLE 73: ASIA-PACIFIC: GENOMICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 74: ASIA-PACIFIC: GENOMICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 75: CHINA: GENOMICS MARKET SIZE, BY PRODUCT AND SERVICE, 2013-2020 (USD MILLION)
  • TABLE 76: CHINA: GENOMICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 77: CHINA: GENOMICS MARKET SIZE, BY PROCESS, 2013-2020 (USD MILLION)
  • TABLE 78: CHINA: GENOMICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 79: CHINA: GENOMICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 80: INDIA: GENOMICS MARKET SIZE, BY PRODUCT AND SERVICE, 2013-2020 (USD MILLION)
  • TABLE 81: INDIA: GENOMICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 82: INDIA: GENOMICS MARKET SIZE, BY PROCESS, 2013-2020 (USD MILLION)
  • TABLE 83: INDIA: GENOMICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 84: INDIA: GENOMICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 85: JAPAN: GENOMICS MARKET SIZE, BY PRODUCT AND SERVICE, 2013-2020 (USD MILLION)
  • TABLE 86: JAPAN: GENOMICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 87: JAPAN: GENOMICS MARKET SIZE, BY PROCESS, 2013-2020 (USD MILLION)
  • TABLE 88: JAPAN: GENOMICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 89: JAPAN: GENOMICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 90: ROAPAC: GENOMICS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 91: ROAPAC: GENOMICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 92: ROAPAC: GENOMICS MARKET SIZE, BY PROCESS, 2013-2020 (USD MILLION)
  • TABLE 93: ROAPAC: GENOMICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 94: ROAPAC: GENOMICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 95: ROW: GENOMICS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 96: ROW: GENOMICS MARKET SIZE, BY PRODUCT AND SERVICE, 2013-2020 (USD MILLION)
  • TABLE 97: ROW: GENOMICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 98: ROW: GENOMICS MARKET SIZE, BY PROCESS, 2013-2020 (USD MILLION)
  • TABLE 99: ROW: GENOMICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 100: ROW: GENOMICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 101: MIDDLE EAST AND AFRICA: GENOMICS MARKET SIZE, BY PRODUCT AND SERVICE, 2013-2020 (USD MILLION)
  • TABLE 102: MIDDLE EAST AND AFRICA: GENOMICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 103: MIDDLE EAST AND AFRICA: GENOMICS MARKET SIZE, BY PROCESS, 2013-2020 (USD MILLION)
  • TABLE 104: MIDDLE EAST AND AFRICA: GENOMICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 105: MIDDLE EAST AND AFRICA: GENOMICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 106: LATIN AMERICA: GENOMICS MARKET SIZE, BY PRODUCT AND SERVICE, 2013-2020 (USD MILLION)
  • TABLE 107: LATIN AMERICA: GENOMICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 108: LATIN AMERICA: GENOMICS MARKET SIZE, BY PROCESS, 2013-2020 (USD MILLION)
  • TABLE 109: LATIN AMERICA: GENOMICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 110: LATIN AMERICA: GENOMICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 111: ILLUMINA, INC.: SEQUENCER SPECIFICATIONS
  • TABLE 112: ILLUMINA, INC.: YEAR-ON-YEAR INCREASE IN THE NUMBER OF COMMERCIAL EMPLOYEES, BY REGION, 2013
  • TABLE 113: NEW PRODUCT LAUNCHES, 2012-2015
  • TABLE 114: AGREEMENTS, CONTRACTS, PARTNERSHIPS, AND COLLABORATIONS, 2012-2015
  • TABLE 115: ACQUISITIONS, 2012-2015
  • TABLE 116: EXPANSIONS, 2012-2015
  • TABLE 117: OTHER DEVELOPMENTS, 2012-2015

LIST OF FIGURES

  • FIGURE 1: GLOBAL GENOMICS MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: SAMPLING FRAME: PRIMARY RESEARCH
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 6: RESEARCH DESIGN
  • FIGURE 7: DATA TRIANGULATION METHODOLOGY
  • FIGURE 8: CONSUMABLES SEGMENT TO DOMINATE THE GENOMICS MARKET IN 2015
  • FIGURE 9: RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES TO DOMINATE THE GENOMICS MARKET IN 2015
  • FIGURE 10: SEQUENCING AND IMAGING SEGMENT TO WITNESS THE HIGHEST GROWTH RATE 2015 TO 2020
  • FIGURE 11: DIAGNOSTICS SEGMENT WILL CONTINUE TO DOMINATE THE GENOMICS MARKET BY 2020
  • FIGURE 12: NORTH AMERICA IS POISED TO GROW AT THE HIGHEST CAGR IN THE FORECAST PERIOD
  • FIGURE 13: INCREASING RESEARCH IN GENOMICS-A MAJOR GROWTH DRIVER FOR THE GENOMICS MARKET FROM 2015 TO 2020
  • FIGURE 14: PCR TECHNOLOGY TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 15: RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES SEGMENT TO DOMINATE THE GENOMICS MARKET IN 2015
  • FIGURE 16: SEQUENCING AND IMAGING SEGMENT TO GROW AT THE HIGHEST CAGR FROM 2015 TO 2020
  • FIGURE 17: NORTH AMERICA TO WITNESS HIGHEST GROWTH RATE IN THE FORECAST PERIOD
  • FIGURE 18: EVOLUTION OF GENOMICS
  • FIGURE 19: GENOMICS MARKET SEGMENTATION
  • FIGURE 20: GENOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
  • FIGURE 21: GENOMICS MARKET, BY PRODUCT
  • FIGURE 22: GENOMICS MARKET, BY TECHNOLOGY
  • FIGURE 23: GENOMICS MARKET, BY PROCESS
  • FIGURE 24: GENOMICS MARKET, BY APPLICATION
  • FIGURE 25: GENOMICS MARKET, BY END USER
  • FIGURE 26: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE GLOBAL GENOMICS MARKET IN 2015
  • FIGURE 27: THE U.S. TO WITNESS HIGHEST GROWTH IN THE NORTH AMERICAN GENOMICS MARKET FROM 2015 TO 2020
  • FIGURE 28: EUROPEAN GENOMICS MARKET SNAPSHOT
  • FIGURE 29: CHINA TO WITNESS HIGHEST GROWTH IN THE APAC GENOMICS MARKET FROM 2015 TO 2020
  • FIGURE 30: LATIN AMERICA TO WITNESS HIGHEST GROWTH IN THE EUROPEAN GENOMICS MARKET FROM 2015 TO 2020
  • FIGURE 31: NEW PRODUCT LAUNCHES WAS THE KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS BETWEEN 2012 AND 2015
  • FIGURE 32: BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES WAS THE KEY STRATEGY ADOPTED BY MARKET PLAYERS (2012-2015)
  • FIGURE 33: GEOGRAPHIC REVENUE MIX OF THE TOP 3 MARKET PLAYERS
  • FIGURE 34: THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
  • FIGURE 35: AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
  • FIGURE 36: AFFYMETRIX, INC.: COMPANY SNAPSHOT
  • FIGURE 37: BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
  • FIGURE 38: CEPHEID, INC.: COMPANY SNAPSHOT
  • FIGURE 39: EUROFINS SCIENTIFIC GROUP : COMPANY SNAPSHOT
  • FIGURE 40: GE HEALTHCARE: COMPANY SNAPSHOT
  • FIGURE 41: ILLUMINA, INC.: COMPANY SNAPSHOT
  • FIGURE 42: QIAGEN N.V.: COMPANY SNAPSHOT
  • FIGURE 43: ROCHE HOLDING AG: COMPANY SNAPSHOT
Back to Top